Oral defense mechanisms are impaired early in HIV-1 infected patients.
about
Natural killer cells regulate murine cytomegalovirus-induced sialadenitis and salivary gland disease.Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohortFurther characterization of human salivary anticandidal activities in a human immunodeficiency virus-positive cohort by use of microassays.Long-Term Trends in Esophageal Candidiasis Prevalence and Associated Risk Factors with or without HIV Infection: Lessons from an Endoscopic Study of 80,219 PatientsImmunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.Oral innate immunity in HIV infection in HAART eraOral and esophageal Candida albicans infection in hyposalivatory ratsEffect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS)Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting
P2860
Q30425772-226CF07A-ECCE-46BF-AC38-4317BAFE532EQ33973443-89CFEE23-99DF-4CB4-8415-3CAE07D93770Q33997988-702E4818-023C-4B05-AF33-A88AFC267CFBQ35711907-FA444567-5D0F-41E4-9529-095D9FED6559Q35920633-991E0B1A-9F13-491F-83D4-AF6D810D05DEQ36352384-2FE0E23B-C5ED-496B-BD6A-AF5E3821B257Q36985626-38DC4ED6-F84E-4E36-A050-CE167D347D3CQ37100683-7BDB4281-BEFB-4331-B473-7339EAFBB12FQ37118999-F386BED5-50D7-4949-A87D-054B18C95400
P2860
Oral defense mechanisms are impaired early in HIV-1 infected patients.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Oral defense mechanisms are impaired early in HIV-1 infected patients.
@en
type
label
Oral defense mechanisms are impaired early in HIV-1 infected patients.
@en
prefLabel
Oral defense mechanisms are impaired early in HIV-1 infected patients.
@en
P2093
P1476
Oral defense mechanisms are impaired early in HIV-1 infected patients.
@en
P2093
Atkinson JC
Bermudez DK
Tylenda CA
P304
P577
1988-01-01T00:00:00Z